School of Chemical Engineering, University of Birmingham, Edgbaston, B15 2TT, United Kingdom; University Hospital Birmingham Foundation Trust, Burns Centre, Mindelsohn Way, B15 2TH Birmingham, United Kingdom; The Scar Free Foundation Birmingham Burn Research Centre, United Kingdom.
School of Chemical Engineering, University of Birmingham, Edgbaston, B15 2TT, United Kingdom.
Acta Biomater. 2019 Apr 15;89:166-179. doi: 10.1016/j.actbio.2019.03.036. Epub 2019 Mar 20.
Autologous cell transplantation was introduced to clinical practice nearly four decades ago to enhance burn wound re-epithelialisation. Autologous cultured or uncultured cells are often delivered to the surface in saline-like suspensions. This delivery method is limited because droplets of the sprayed suspension form upon deposition and run across the wound bed, leading to uneven coverage and cell loss. One way to circumvent this problem would be to use a gel-based material to enhance surface retention. Fibrin systems have been explored as co-delivery system with keratinocytes or as adjunct to 'seal' the cells following spray delivery, but the high costs and need for autologous blood has impeded its widespread use. Aside from fibrin gel, which can exhibit variable properties, it has not been possible to develop a gel-based carrier that solidifies on the skin surface. This is because it is challenging to develop a material that is sprayable but gels on contact with the skin surface. The manuscript reports the use of an engineered carrier device to deliver cells via spraying, to enhance retention upon a wound. The device involves shear-structuring of a gelling biopolymer, gellan, during the gelation process; forming a yield-stress fluid with shear-sensitive behaviours, known as a fluid gel. In this study, a formulation of gellan gum fluid gels are reported, formed with from 0.75 or 0.9% (w/v) polymer and varying the salt concentrations. The rheological properties and the propensity of the material to wet a surface were determined for polymer modified and non-polymer modified cell suspensions. The gellan fluid gels had a significantly higher viscosity and contact angle when compared to the non-polymer carrier. Viability of cells was not impeded by encapsulation in the gellan fluid gel or spraying. The shear thinning property of the material enabled it to be applied using an airbrush and spray angle, distance and air pressure were optimised for coverage and viability. STATEMENT OF SIGNIFICANCE: Spray delivery of skin cells has successfully translated to clinical practice. However, it has not yet been widely accepted due to limited retention and disputable cell viability in the wound. Here, we report a method for delivering cells onto wound surfaces using a gellan-based shear-thinning gel system. The viscoelastic properties allow the material to liquefy upon spraying and restructure rapidly on the surface. Our results demonstrate reduced run-off from the surface compared to currently used low-viscosity cell carriers. Moreover, encapsulated cells remain viable throughout the process. Although this paper studies the encapsulation of one cell type, a similar approach could potentially be adopted for other cell types. Our data supports further studies to confirm these results in in vivo models.
自体细胞移植在近 40 年前被引入临床实践,以增强烧伤创面的再上皮化。自体培养或未培养的细胞通常以类似于盐水的悬浮液形式输送到表面。这种输送方法是有限的,因为喷洒悬浮液的液滴在沉积时形成并在创面床上流动,导致覆盖不均匀和细胞损失。解决这个问题的一种方法是使用基于凝胶的材料来增强表面保留。纤维蛋白系统已被探索用作角质形成细胞的共输送系统,或作为喷雾输送后“密封”细胞的辅助手段,但高成本和需要自体血液阻碍了其广泛应用。除了纤维蛋白凝胶,其性能可能会有所不同外,目前还不可能开发出一种在皮肤表面固化的基于凝胶的载体。这是因为开发一种可喷涂但与皮肤表面接触时会凝胶的材料具有挑战性。本文报道了使用工程载体装置通过喷雾输送来输送细胞,以增强在伤口上的保留。该装置涉及在凝胶化过程中对凝胶形成生物聚合物(即结冷胶)进行剪切结构化;形成具有剪切敏感行为的屈服应力流体,称为流变体凝胶。在这项研究中,报道了一种结冷胶流体凝胶的配方,其聚合物浓度为 0.75%或 0.9%(w/v),并改变盐浓度。为聚合物改性和非聚合物改性的细胞悬浮液确定了材料的流变特性和润湿表面的倾向。与非聚合物载体相比,结冷胶流体凝胶的粘度和接触角明显更高。细胞的活力不受结冷胶流体凝胶包封或喷雾的阻碍。材料的剪切变稀特性使其能够使用喷枪应用,并且优化了喷雾角度、距离和空气压力以实现覆盖和活力。意义声明:皮肤细胞的喷雾输送已成功转化为临床实践。然而,由于保留有限和伤口中细胞活力存在争议,它尚未被广泛接受。在这里,我们报告了一种使用基于结冷胶的剪切稀化凝胶系统将细胞递送到创面表面的方法。粘弹性允许材料在喷雾时液化,并在表面上迅速重新结构。与目前使用的低粘度细胞载体相比,我们的结果表明从表面上的流失减少。此外,封装的细胞在整个过程中保持活力。尽管本文研究了一种细胞类型的封装,但类似的方法可能适用于其他细胞类型。我们的数据支持进一步的研究,以在体内模型中确认这些结果。